Preleukemia  >>  Soliris (eculizumab)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Soliris (eculizumab) / AstraZeneca
NCT01412047: Paroxysmal Nocturnal Hemoglobinuria Human Anti-Human Antibodies Study

Completed
N/A
75
US, Europe, RoW
Alexion Pharmaceuticals
Paroxysmal Nocturnal Hemoglobinuria, PNH
06/13
06/13
EMBRACE, NCT00438789: The Paroxysmal Nocturnal Hemoglobinuria Early Access Treatment Protocol

Approved for marketing
N/A
US
eculizumab
Alexion Pharmaceuticals
Hemoglobinuria, Paroxysmal
 
 

Download Options